Consensus NICE Ltd. OTC Markets

Equities

NCSYF

IL0002730112

Market Closed - OTC Markets Other stock markets 14:53:39 15/05/2024 BST			5-day change	1st Jan Change
222.4 ^USD	+1.17%		+1.17%	+12.87%

12:41pm	RBC Cuts Price Target on NICE to $265 From $285, Says 'CEO Transition Represents Meaningful Risk,' Keeps Outperform Rating	MT
05-16	Top Midday Decliners	MT

Evolution of the average Target Price on NICE Ltd.

Price target over the last 5 years

History of analyst recommendation changes

ab85bd41fb9a232974dd08653ca60.nFNMB3PUisRA9PPYGt-trVlcEy-4LmH2GqavvDDaA7I.zwcmRhfg6PIKpbCeN4f_4wsKW2fOZw2RSfn23XKqUuP7Oh81Ppvk6SaDgA~c01d42b565a9c3e688fdc76ed2515ce0

Analyst Recommendations on NICE Ltd.

RBC Cuts Price Target on NICE to $265 From $285, Says 'CEO Transition Represents Meaningful Risk,' Keeps Outperform Rating	11:41am	MT
DA Davidson Upgrades NICE to Buy From Neutral, Adjusts Price Target to $300 From $250	03-13	MT
Mizuho Ups Price Target on NICE to $300 From $244, Keeps Buy Rating	02-23	MT
Barclays Raises NICE's Price Target to $320 From $283, Keeps Overweight Rating	02-23	MT
Oppenheimer Raises NICE Price Target to $300 From $225, Maintains Outperform Rating	02-23	MT
RBC Raises Price Target on NICE to $285 From $238, Keeps Outperform Rating	02-23	MT
Wedbush Raises NICE's PT to $270 From $230 After 'Strong' Q4 2023 Results, Keeps Outperform Rating	02-23	MT
Citigroup Adjusts NICE's Price Target to $334 From $283, Keeps Buy Rating	02-21	MT
Morgan Stanley Raises Price Target on NICE to $260 From $220, Keeps Overweight Rating	12-14	MT
Morgan Stanley Upgrades NICE to Overweight From Equalweight, Cuts Price Target to $220 From $225	16/10/23	MT
Oppenheimer Adjusts NICE Price Target to $225 From $250, Maintains Outperform Rating	05/10/23	MT
Citigroup Adjusts NICE Price Target to $338 From $278, Maintains Buy Rating	15/08/23	MT
William Blair Starts NICE at Outperform	26/07/23	MT
Mizuho Initiates NICE at Buy With $244 Price Target	31/05/23	MT
Jefferies Adjusts Price Target on NICE to $235 From $260, Keeps Buy Rating	12/05/23	MT
Wedbush Cuts NICE's Price Target to $230 From $250 Reflecting Lower Multiple, Keeps Outperform Rating	12/05/23	MT
Citigroup Adjusts Price Target on NICE to $278 From $277, Keeps Buy Rating	10/05/23	MT
Piper Sandler Upgrades NICE to Overweight From Neutral, Adjusts Price Target to $227 From $222	17/01/23	MT
RBC Capital Adjusts Price Target on NICE to $238 From $265, Maintains Outperform Rating	10/01/23	MT
Citigroup Adjusts Price Target on NICE to $260 From $254, Maintains Buy Rating	11/11/22	MT
Morgan Stanley Adjusts NICE's Price Target to $215 from $235, Retains Equalweight Rating	11/10/22	MT
Piper Sandler Starts NICE at Neutral With $236 Price Target	25/08/22	MT
Wedbush Adjusts Price Target on NICE to $250 From $220, Citing Cloud Revenue, Keeps Outperform Rating	22/08/22	MT
RBC Raises Price Target on NICE to $265 From $240, Citing 'Clean' Q2 With Margin Expansion, 2022 Guidance Boost; Outperform Kept	19/08/22	MT
Barclays Adjusts Price Target on NICE to $283 From $356, Reiterates Overweight Rating	26/07/22	MT